<i>MKX-AS1</i> Gene Expression Associated with Variation in Drug Response to Oxaliplatin and Clinical Outcomes in Colorectal Cancer Patients

Oxaliplatin (OXAL) is a commonly used chemotherapy for treating colorectal cancer (CRC). A recent genome wide association study (GWAS) showed that a genetic variant (rs11006706) in the lncRNA gene <i>MKX-AS1</i> and partnered sense gene <i>MKX</i> could impact the response of genetically varied cell...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Ricardo D. Gonzalez, George W. Small, Adrian J. Green, Farida S. Akhtari, Alison A. Motsinger-Reif, Julia C. F. Quintanilha, Tammy M. Havener, David M. Reif, Howard L. McLeod, Tim Wiltshire
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2023-05-01
Serie:	Pharmaceuticals
Soggetti:	precision medicine colorectal cancer pharmacogenomics oxaliplatin lncRNA’s antisense
Accesso online:	https://www.mdpi.com/1424-8247/16/5/757
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!